An Open Label Phase I/II Study of the Safety and Dopamine Transporter Binding Properties of C-11 Altropane in Normal Human Subjects and in Subjects With ADHD

Clinical trial NCT00302380 · COMPLETED

Trial details

NCT number: NCT00302380
Sponsor: Massachusetts General Hospital
Status: COMPLETED
Study type: OBSERVATIONAL

Attention Deficit Hyperactivity Disorder

Start date: 2000-10-01
Primary completion: 2006-03-01
Enrollment: 300

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.